Latest filing published 08 Oct 2014 for GENEREX BIOTECHNOLOGY CORP.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Brian Mcgee: trading record in brief
Brian Mcgee discloses dealings in Generex Biotechnology Corp to SEC (Form 4). The record holds 5 filings, for trades running from 28 February 2006 to 6 October 2014.
Every open-market trade on record is a purchase: 2 purchases worth €199k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 1 option exercise.
The newest entry dates from 8 October 2014: an option exercise, in Generex Biotechnology Corp. The last purchase on record was published on 28 March 2006, which is 7,530 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Mcgee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,714 shares0Common StockSEC:0001363585-14-000001:0
- 150,000 shares0Common StockSEC:0001125282-06-003148:0
- 26,000 shares@ US$3.22Common StockSEC:0001125282-06-001835:0Canonical exit: 25 Jun 2006 (T+90)
- 4,000 shares@ US$3.02Common StockSEC:0001125282-06-001835:1
- 70,000 shares@ US$2.21Common StockSEC:0001125282-06-001404:0Canonical exit: 29 May 2006 (T+90)
5 of 5 declarations